Methods: We performed analyses on RNA-seq and microarray datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO ... All experiments were performed in triplicate. The colony ...

The blood-based assay uses epigenomic analysis to detect circulating tumor DNA to predict cancer recurrence. "Utilizing ctDNA testing in the surveillance setting alongside standard-of-care monitoring, ...

The ChemoFx® treatment selection marker and tumor profiling assay will initially focus on ovarian and other gynecological cancers and may include testing of other major tumor types of interest ...

“There is still so much we need to learn about prostate cancer, and we eagerly look forward to seeing how this work progresses over the coming years.” Reference: Francis JC, Capper A, Rust AG, et al.

Double genetic ablation of Fbxo45 and Arhgef2 ameliorated lymphoma formation. Transgenic knock-in mice harboring a GEF-H1 mutant unable ... These results identify FBXO45 and ARHGEF2 as a novel ...

Kenny will have a 12-day-long residency at the popular Sphere venue. His concert dates will include: May 22, 24-25, 28, 30-31, June 4, 6-7, 11, and 13-14. How Much Are Kenny Chesney’s Sphere ...

(NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated flagship live cell ChemoFx® drug response assay in Europe and expanded availability in the United ...

1Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China. 2Department of Cell Biology, Zhejiang University School of Medicine, ...

Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec H3T 1E2, Canada Division of Experimental Medicine, McGill ...

Glioblastoma(GBM) is a highly malignant primary central nervous system tumor that poses a significant threat to patient survival due to its treatment resistance and rapid recurrence.Current treatment ...